ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Sawvic
|
2.7K |
1.1M |
0 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Media News
|
|
Sawvic
|
221 |
97K |
0 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
221
|
97K
|
0
|
|
ASX - By Stock
|
MDR |
Re:
Ann: Change in substantial holding
|
|
Sawvic
|
10 |
4.9K |
0 |
05/03/23 |
05/03/23 |
ASX - By Stock
|
10
|
4.9K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
7 Days till lift off ! Or earlier ? FDA announcement prediction, nearest to the pin, hour and date AEST ?
|
|
Sawvic
|
154 |
76K |
5 |
05/03/23 |
05/03/23 |
ASX - By Stock
|
154
|
76K
|
5
|
|
ASX - By Stock
|
CYC |
Re:
Big Week Ahead
|
|
Sawvic
|
4 |
1.1K |
1 |
18/02/23 |
18/02/23 |
ASX - By Stock
|
4
|
1.1K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Silence is Deafening
|
|
Sawvic
|
5 |
1.6K |
1 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
5
|
1.6K
|
1
|
|
ASX - By Stock
|
ADR |
Re:
Investors Q and A
|
|
Sawvic
|
25 |
6.2K |
1 |
05/02/23 |
05/02/23 |
ASX - By Stock
|
25
|
6.2K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
FDA Response
|
|
Sawvic
|
1 |
838 |
2 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
1
|
838
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Director Appointment/Resignation
|
|
Sawvic
|
6 |
1.8K |
0 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
6
|
1.8K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Director Appointment/Resignation
|
|
Sawvic
|
6 |
1.8K |
1 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
6
|
1.8K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Director Appointment/Resignation
|
|
Sawvic
|
6 |
1.8K |
0 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
6
|
1.8K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Why are we waiting
|
|
Sawvic
|
3 |
1.5K |
2 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
3
|
1.5K
|
2
|
|
Charts
|
NEU |
Re:
ASX 200 - March rebalance
|
|
Sawvic
|
54 |
29K |
5 |
05/01/23 |
05/01/23 |
Charts
|
54
|
29K
|
5
|
|
Charts
|
NEU |
Re:
ASX 200 - March rebalance
|
|
Sawvic
|
54 |
29K |
13 |
04/01/23 |
04/01/23 |
Charts
|
54
|
29K
|
13
|
|
Charts
|
NEU |
ASX 200 - March rebalance
|
|
Sawvic
|
54 |
29K |
43 |
04/01/23 |
04/01/23 |
Charts
|
54
|
29K
|
43
|
|
ASX - By Stock
|
CYC |
Re:
Happy New Year
|
|
Sawvic
|
3 |
1.8K |
1 |
01/01/23 |
01/01/23 |
ASX - By Stock
|
3
|
1.8K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Bell Potter Healthcare Conference
|
|
Sawvic
|
7 |
3.4K |
0 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
7
|
3.4K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
How Close Are We
|
|
Sawvic
|
14 |
4.3K |
2 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
14
|
4.3K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Sawvic
|
10 |
4.9K |
6 |
22/10/22 |
22/10/22 |
ASX - By Stock
|
10
|
4.9K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Sawvic
|
10 |
4.9K |
2 |
22/10/22 |
22/10/22 |
ASX - By Stock
|
10
|
4.9K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Trading Halt
|
|
Sawvic
|
5 |
1.7K |
0 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
5
|
1.7K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
How Close Are We
|
|
Sawvic
|
14 |
4.3K |
0 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
14
|
4.3K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
How Close Are We
|
|
Sawvic
|
14 |
4.3K |
1 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
14
|
4.3K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Sawvic
|
2.7K |
1.1M |
3 |
02/10/22 |
02/10/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Pharmaceuticals with Proactive at ASX Small and Mid-Cap Conference
|
|
Sawvic
|
78 |
39K |
0 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
78
|
39K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: 2022 AGM & Key Dates
|
|
Sawvic
|
10 |
4.1K |
11 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
10
|
4.1K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Pharmaceuticals with Proactive at ASX Small and Mid-Cap Conference
|
|
Sawvic
|
78 |
39K |
2 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
78
|
39K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
IMM vs IMU
|
|
Sawvic
|
11 |
3.7K |
4 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
11
|
3.7K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
FDA submission
|
|
Sawvic
|
3 |
1.5K |
5 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
3
|
1.5K
|
5
|
|
ASX - By Stock
|
IMM |
Marc or Mark, it's MARC
|
|
Sawvic
|
7 |
2.7K |
0 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
7
|
2.7K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Pharmamaxis Tropical Drug Scar trial Featured on TV News
|
|
Sawvic
|
9 |
4.6K |
0 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
9
|
4.6K
|
0
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Phase II Results
|
|
Sawvic
|
140 |
32K |
1 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
140
|
32K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: 1H 2022 Business Update - Record Revenues
|
|
Sawvic
|
1 |
768 |
2 |
04/07/22 |
04/07/22 |
ASX - By Stock
|
1
|
768
|
2
|
|
ASX - By Stock
|
CYC |
Re:
FDA APPROVAL
|
|
Sawvic
|
19 |
6.6K |
1 |
12/06/22 |
12/06/22 |
ASX - By Stock
|
19
|
6.6K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Confirm Diagnostic Method on Depression Validation Trial
|
|
Sawvic
|
49 |
15K |
3 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
49
|
15K
|
3
|
|
ASX - By Stock
|
CYC |
Re:
News: CYC Cyclopharm Says Technegas Shown To Have Key Role In COVID-19 Diagnosis & Management
|
|
Sawvic
|
2 |
907 |
1 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
2
|
907
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Sawvic
|
382 |
194K |
0 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
382
|
194K
|
0
|
|
ASX - By Stock
|
TRI |
Re:
MEB medibio
|
|
Sawvic
|
97 |
28K |
1 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
97
|
28K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
MEB medibio
|
|
Sawvic
|
97 |
28K |
1 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
97
|
28K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm USFDA Update
|
|
Sawvic
|
23 |
9.1K |
1 |
15/05/22 |
15/05/22 |
ASX - By Stock
|
23
|
9.1K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
RNA-based+2591PW
|
|
Sawvic
|
7 |
4.3K |
2 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
7
|
4.3K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
A De-risked bio-tech with 4X upside - Karst Peak Capital
|
|
Sawvic
|
73 |
44K |
3 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
73
|
44K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2021 Results - a transformational year for Neuren
|
|
Sawvic
|
75 |
35K |
2 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
75
|
35K
|
2
|
|
ASX - By Stock
|
CYC |
Re:
News: CYC Cyclopharm Posts FY Sales Revenue Of A$17.70 Million
|
|
Sawvic
|
1 |
538 |
2 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
1
|
538
|
2
|
|
ASX - By Stock
|
NEU |
Re:
A De-risked bio-tech with 4X upside - Karst Peak Capital
|
|
Sawvic
|
73 |
44K |
20 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
73
|
44K
|
20
|
|
ASX - By Stock
|
NEU |
A De-risked bio-tech with 4X upside - Karst Peak Capital
|
|
Sawvic
|
73 |
44K |
28 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
73
|
44K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2021 Results - a transformational year for Neuren
|
|
Sawvic
|
75 |
35K |
15 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
75
|
35K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sawvic
|
10K |
4.9M |
1 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
10K
|
4.9M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sawvic
|
10K |
4.9M |
1 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
10K
|
4.9M
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Sawvic
|
10K |
4.9M |
7 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
10K
|
4.9M
|
7
|
|